Taming the malaria scourge
By Sun News Publishing
Friday, June 27, 2008

The recent statement credited to the Kano State Commissioner for Health, Malama Aisha Ishiaku, that malaria scourge accounts for an annual economic burden of about N132 billion in Nigeria has, once again, drawn attention to the intolerable status of the debilitating disease in the country.

The condition is said to be responsible for an estimated 30 percent of deaths among children, 11 percent among pregnant women and 80 percent of diseases in reported cases in health facilities. It is certainly the leading cause of morbidity and mortality in the country.

Available records show that 50 percent of Nigeria’s population suffers from, at least, one episode of malaria attack each year. The disease accounts for over 45 percent of all out-patient visits.
About 300,000 Nigerians, mostly children below five years, die annually from the disease. It is estimated that five percent of the children born in the country die annually of the scourge.

Malaria is also responsible for 25 percent of childhood deaths while it incapacitates over five million Nigerians annually. The economic impact of the disease can be better appreciated in terms of costs to families who provide treatment and preventive measures. It also includes costs to the government, which spends funds on awareness campaigns and provides malaria control measures. It involves programmes such as the Roll Back Malaria initiative of the federal government and costs due to reduced economic activities in victims as well as premature deaths.
In highly endemic countries, the disease has led to a deficit in Gross Domestic Product (GDP) estimated yearly at 1.3 percent.

In Nigeria, malaria is directly or remotely responsible for the loss of millions of productive hours, resulting in colossal reduction in individual and collective productivity.
In Africa, malaria accounts for 10 percent of the continent’s disease burden as well as the $12 billion yearly lost in productivity.
Globally, about 40 percent of world population (2.4 billion) is known to be at risk. An estimated 300-500 million cases of malaria occur globally every year.

The prevailing high incidence of malaria in Nigeria is indeed unacceptable considering the fact that the disease is both preventable and curable. We cannot at this level of our development continue to lose billions of naira to malaria either to drugs for treatment or to lost man-hours occasioned by the disease. It is regrettable that this treatable condition is responsible for the high child and maternal morbidity and mortality in the country.

Knowing full well that this disease is preventable and curable, we advise that the three levels of government in the country jointly and singly take proactive measures to stem and tame the endemic disease.

Although the malaria parasite has, over time, developed resistance to some of the first line drugs for its treatment like chloroquine, the good news is that there are other available efficacious malaria drugs that can overcome such resistance and effect the needed cure.
Nevertheless, the government must ensure that Nigerians, especially those in rural areas, have access to health facilities where they can avail themselves of prompt malaria treatment and at affordable costs too.

While we enjoin those infected by the condition to go for treatment at the nearest health facility, we advise that more spirited efforts be geared towards vector control. Such control measures include the use of insecticides for destroying mosquito larvae and adult forms and destroying breeding places for mosquitoes, the use of insecticide-treated bed nets and cleaning of surroundings, among others.
However, there is the need for the government to intensify research to discover potent malaria vaccine that experts believe will deal a lethal blow to the ubiquitous and menacing disease condition.


 

 

 

 

HOME | ABOUT THE SUN | SPORTS | POLITICS | NEWS | COLUMNISTS | CONTACT US | ADVERT RATE
© 2007 THE SUN PUBLISHING LTD. This service is provided on The Sun Newspapers' standard terms and conditions in accordance with our Privacy Policy.
To inquire about a licence to reproduce material and other inquiries, Contact Us.